• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 51 of 100
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
Health
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By David MeyerMay 18, 2018
The American Enterprise Institute photo of Scott Gottlieb
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By Sy MukherjeeMay 17, 2018
Doctor in white lab coat grips stethoscope
Health
An All-Star Panel Tackles Trump’s Drug Price Plan, Innovation in Health Care—And More
By Sy MukherjeeMay 16, 2018
Johnson And Johnson Recalls Children's Cold Medicines
Health
We Don’t Have a Cure for the Common Cold. But This New Treatment Might Stop It in Its Tracks
By Sy MukherjeeMay 14, 2018
President Trump Delivers Remarks On Lowering Drug Prices In Rose Garden
Health
Why Trump’s Big Drug Price Speech Sent Health Care Stocks Soaring
By Sy MukherjeeMay 11, 2018
IL: Corporations In Illinois
Health
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
By David MeyerMay 8, 2018
Sanofi Presents Its Annual Results
Health
A $14,000 Cholesterol Drug Is Getting A 69% Price Cut
By Kirsten KorosecMay 1, 2018
A Pfizer sign hangs on the outside of their headquarters in New York City.
Health
Why Pfizer and Merck Stock Both Slumped After Their Earnings Reports
By Sy MukherjeeMay 1, 2018
How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma
Health
How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma
By Elizabeth Lucas, Jay Hancock, Kaiser Health News and Anne VanderMeyApril 26, 2018
Marijuana Cultivation Center In Nevada Ramps Up Production As State Legalizes Recreation Use Of Weed
Health
Epilepsy Drug Made From Marijuana Plant Gets Backing From FDA Staff
By Bloomberg and Wilder DaviesApril 17, 2018
Lung cancer on the left pulmonary lobe, seen on a frontal X-ray of the chest.
Health
Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer
By Sy MukherjeeApril 16, 2018
Hepatitis C drug can cure, if patients can get it
Health
Hepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300
By Sy MukherjeeApril 12, 2018
Alzheimers-dementia-brain-research
Health
Researchers Just Proposed a Radical New Way of Defining Alzheimer’s. Could It Lead to Better Drugs?
By Sy MukherjeeApril 10, 2018
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
Health
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
By Sy MukherjeeApril 9, 2018
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
Health
Why Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
By Hallie DetrickApril 9, 2018
1...
  • 49
  • 50
  • 51
  • 52
  • 53
...100
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Economy
Economists have found an answer to slowing cognitive decline: Avoid retiring early, study findsplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.